upcyte technologies is a life science company specialized in the controlled, scalable propagation and standardization of human primary cell products.
The company is currently located in Hamburg-Eppendorf, Germany, where new and well-equipped product development labs and production facilities were established. upcyte technologies has developed unique cell proliferation platforms that form the basis for novel cell-based research and drug development tools and future cell therapy products.
Differentiated primary cells have no or only limited proliferation capacities. The company's technology, however, allow controlled proliferation beyond normal life span of primary cells without loss of their phenotypic or differentiation properties and without immortalization. Our vision is to establish its unique technology as gold standard and preferred source of cell-based products for research, industrial development and therapeutic applications.
The company is ideally positioned to capitalize on the increasing demand for well-characterized primary cell products.